TipRanks
ADC Therapeutics Ltd (ADCT)
NYSE:ADCT
US Market
ADCT
ADC Therapeutics
RESEARCH TOOLSreports
Want to see ADCT full AI Analyst Report?

ADC Therapeutics (ADCT) Stock News & Sentiment

440 Followers
ADC Therapeutics Announces Major Financial Restructuring Initiatives
Premium
Company Announcements
ADC Therapeutics Announces Major Financial Restructuring Initiatives
2h ago
8K
ADCT
ADC Therapeutics Balances Earnings Gains With Trial Risks
Premium
Company Announcements
ADC Therapeutics Balances Earnings Gains With Trial Risks
2M ago
ADCT
ADC Therapeutics Reports Q2 2026 Results, Reassesses ZYNLONTA Path
Premium
Company Announcements
ADC Therapeutics Reports Q2 2026 Results, Reassesses ZYNLONTA Path
2M ago
8K
ADCT
ADCT Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ADCT Upcoming Earnings Report: What to Expect?
2M ago
ADCT
ADC Therapeutics Halts LOTIS-10 Liver-Impairment Study: What It Means for Zynlonta and Investors
Premium
Company Announcements
ADC Therapeutics Halts LOTIS-10 Liver-Impairment Study: What It Means for Zynlonta and Investors
3M ago
ADCT
ADC Therapeutics Grants One-Time Retention Awards to Executives
Premium
Company Announcements
ADC Therapeutics Grants One-Time Retention Awards to Executives
3M ago
8K
ADCT
ADC Therapeutics Announces ZYNLONTA-Focused Strategic Reorganization
Premium
Company Announcements
ADC Therapeutics Announces ZYNLONTA-Focused Strategic Reorganization
4M ago
8K
ADCT
More ADCT News >

ADCT News on the Web

ADC Therapeutics (ADCT) Navigates FDA Setback While Cutting Its Losses
Insider Monkey
Neutral
ADC Therapeutics (ADCT) Q2 2026 Earnings Call Transcript
The Motley Fool
Neutral
ADCT Upcoming Earnings Report: What to Expect?
TipRanks News
Neutral
ADC Therapeutics Halts LOTIS-10 Liver-Impairment Study: What It Means for Zynlonta and Investors
TipRanks News
Bearish
ADC Therapeutics Grants One-Time Retention Awards to Executives
TipRanks News
Neutral
Analysts Are Bullish on Top Healthcare Stocks: ADC Therapeutics (ADCT), Moleculin Biotech (MBRX)
TipRanks News
Neutral
ADC Therapeutics completes enrollment in Phase 1b Zynlonta trial
TipRanks News
Bearish
ADC Therapeutics Cuts Workforce To Advance ZYNLONTA Portfolio In B-Cell Lymphoma
rttnews
Bullish

News Score - Last 7 Days

Positive
ADCT
Sector Average
Media Buzz
This Week5 articles
Weekly Average0 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ADCT’s Media Buzz Sentiment?
Currently, no data Available
What is ADCT’s weekly average amount of articles?
Currently, no data Available
What is ADCT’s News Sentiment?
100% of articles about ADCT were positive this week, compared to its sector average of 91%.
    Healthcare Stocks that are Trending in the News
    IQVIQVIA Holdings
    GILDGilead Sciences
    ABBVAbbVie
    VRTXVertex Pharmaceuticals
    NVSNovartis
    Showing the stocks with the most bullish news sentiment over the past week